Approval · Notice of Compliance 10010 · 2009
CLOPIXOL: Notice of Compliance 10010
Issued January 27, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10010
- Date
- January 27, 2009
- Company
- Lundbeck Canada IncSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the Dosage & Administration section and other revisions to the Product Monograph
- Therapeutic class
- Antipsychotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLOPIXOL | Not yet assigned | — |
| CLOPIXOL DEPOT | Not yet assigned | — |
| CLOPIXOL ACUPHASE | Not yet assigned | — |
Medicinal ingredients
- ZUCLOPENTHIXOL HYDROCHLORIDE 10 MG per TAB
- ZUCLOPENTHIXOL HYDROCHLORIDE 25 MG per TAB
- ZUCLOPENTHIXOL DECANOATE 200 MG per ML
- ZUCLOPENTHIXOL ACETATE 50 MG per ML